Exagen Diagnostics, Inc. is a patient focused, discovery driven, CLIA registered, CAP accredited laboratory with a growing menu of proprietary, internally developed tests focused on Rheumatology.
Committed to Personalized Medicine, our tests are specifically designed to provide objective information to physicians and patients for more accurate, efficient diagnosis and better disease management.
Using uniquely powerful Coperna® discovery technology, Exagen identifies and validates small sets of genomic markers. These are used to create meaningful, easily interpreted diagnostic tests for clinical use in our CLIA laboratory. In addition, we work with pharmaceutical and diagnostic company partners to discover and develop tests that are specific for their product needs.
Exagen's proprietary computational engine, Coperna®, enables us to discover accurate genomic marker sets across the spectrum of genomic data types, including the latest high density gene expression and SNP arrays. Other groups, using less powerful discovery techniques, will likely not identify marker sets approaching the performance of our Coperna-generated discoveries. Our superior 'hit rate' is a result of Coperna's deeper search of genomic data for accurate marker sets, and following this, our validation that the identified marker sets are truly significant. The end result: high confidence that subsequent clinical studies will validate our computational discoveries.
Even though the technology behind our discoveries may be 'bleeding edge', our marker sets can be implemented using technologies most appropriate for high volume clinical lab use. Marker sets of high potential clinical value can be developed into an assay suited for the intended application, whether that be disease diagnosis, prognosis, susceptibility, or prediction of likely treatment response.
Exagen is committed to translating our discovery and development into real solutions that are safe, reliable and cost effective.
To discover, develop, validate and deliver high value molecular diagnostic laboratory testing services to physicians, clinical laboratories, and pharmaceutical companies on a worldwide basis.
The medical community, when faced with challenging health care decisions, chooses Exagen's revolutionary genomic-based molecular diagnostic laboratory testing services to improve patient care and quality of life.